CSL sets October 27 AGM in Melbourne for CSL stock

Published on 10/13/2026 at 13:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CSL closed at AUD 184.58 on October 13, 2026. CSL stock costs EUR 115.35 on October 13, 2026, down 0.12 percent on ASX during trading.

CSL's annual general meeting is scheduled for October 27, 2026, in Melbourne.
CSL Limited closed at AUD 184.58 on October 13, 2026, down 0.12 percent on the ASX.
CSL stock traded at EUR 115.35 at Lang & Schwarz on October 13, 2026 at 1:33 p.m. CEST, down 0.12 percent on the ASX versus AUD 184.81.
Market capitalization was AUD 88.4 billion, while 579,614 shares traded against a 1,281,785 average.

CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL's annual general meeting is scheduled for October 27, 2026, in Melbourne, according to Simply Wall St. The date gives investors the next formal checkpoint after a sharp recovery in the Australian-listed shares. CSL stock was at EUR 115.35 at Lang & Schwarz on October 13, 2026 at 1:33 p.m. CEST, down 0.12 percent on the ASX versus the ASX prior close of AUD 184.81.

October 27 sets the next checkpoint

The meeting will take place at Sofitel Melbourne on Collins, according to the dated corporate calendar entry carried by Simply Wall St. For investors, the date matters because it is the next scheduled setting for questions on CSL's operating recovery, capital allocation and vaccine business strategy.

Shares remain below the yearly high

CSL Limited closed at AUD 184.58 on the ASX on October 13, 2026, against a 52-week range of AUD 90.00 to AUD 222.47. The closing level stood 17.03 percent below the 52-week high, while the session loss was 0.12 percent versus AUD 184.81.

Trading volume was 579,614 shares, compared with an average of 1,281,785 shares. That puts the session volume 54.78 percent below the average, a more subdued turnover profile than the recent benchmark for the stock.

Market value and business profile

CSL's market capitalization was AUD 88.4 billion on October 13, 2026. The finance profile classifies the company in healthcare and biotechnology, with CSL Behring and CSL Seqirus as its two principal operating segments and 29,000 full-time employees.

The price picture remains split by venue: the Australian listing closed at AUD 184.58, while the German euro indication was EUR 115.35 at 1:33 p.m. CEST. Those figures use different currencies and venues, so the ASX percentage is kept separate from the Lang & Schwarz euro price.

Comparison with peers

CSL: down 0.12 percent, market capitalization AUD 88.4 billion.
Grifols (BME, EUR): down 1.38 percent, P/E 14.76, market capitalization EUR 6.7 billion.
Takeda (TSE, JPY): market capitalization USD 59.4 billion, P/E 53.16.

Trading stays close to EUR 115

At Lang & Schwarz, CSL stock was at EUR 115.35 on October 13, 2026 at 1:33 p.m. CEST, down 0.12 percent on the ASX versus the ASX prior close of AUD 184.81. The further course of trading is shown by the continuously updated real-time quote of CSL stock.